Otrivin Baby Care Moisturising Nasal Spray

Otrivin Baby Care Moisturising Nasal Spray is an isotonic saline solution. The salt concentration is optimised to prevent any nasal irritation. The solution contains castor oil (macrogol glycerol hydroxystearate) which is known to have moisturising and emollient properties.

Otrivin Baby Care Moisturising Nasal Spray is recommended to:

• Gently cleanse the nasal cavities when the nose is blocked, e.g. during a cold or in allergic conditions, by washing away the excess mucus or the allergen particles such as dust or pollen

• Moisturise the nasal mucosa when dry or irritated in case of minor nasal irritations or due to low humidity (e.g. due to heated/airconditioned rooms, high altitude, air travelling)

• Thin and loosen nasal secretions and help their removal.

OTRIVIN BABY CARE moisturising nasal spray

Ingredients and Instructions for use.

Ingredients list: 0.74 % sodium chloride, macrogol glycerol hydroxystearate (castor oil), benzalkonium chloride, disodium edetate, sodium dihydrogen phosphate dihydrate, disodium phosphate anhydrous and purified water.

Otrivin Baby Care Moisturising Nasal Spray contains benzalkonium chloride, a quaternary ammonium which could cause a local allergy in those sensitive to this substance. Do not use the product if you are allergic to any of the ingredients. (See Ingredients list).

Do not use a broken or damaged product.

You should consult a doctor before using Otrivin Baby Care Moisturising Nasal Spray following a nasal operation or injury. Due to its cleansing properties, Otrivin Baby Care Moisturising Nasal Spray should be used first when using another local nasal product (e.g. for cold or allergic rhinitis). Otrivin Baby Care Moisturising Nasal Spray may be used during pregnancy and breast-feeding, ask your doctor or pharmacist before using it.

How to use Otrivin Baby Care Moisturising Nasal Spray

The usual frequency of use is 2 to 4 times a day per nostril. Suitable for infants, children and adults. However, you should seek medical advice before using it on an infant less than 2 weeks old. For children below 11 years, Otrivin Baby Care Moisturising Nasal Spray should be used under adult supervision. In elderly or disabled people, the use of the device may require help from an adult. For infants and toddlers (up to 2 years): 1 spray in each nostril as needed. For Adults and children (over 2 years): 1 or 2 sprays in each nostril as required. For hygienic reasons and to avoid contamination, the nasal spray should be used by one person.

    1. Blow the nose if necessary.

    2. Before and after using Otrivin Baby Care Moisturising Nasal Spray, wash your hands carefully.

    3. Remove the protective cap of the metered-dose spray.

    4. Hold the bottle with thumb at base and nozzle between second and third fingers. When using the bottle for the first         time, prime the metered-dose spray by spraying several times into the air until an even spray emerges. The         metered-dose spray is then ready to use.

    5. Carefully insert the tip of the nozzle just inside the nostril. Spray one puff at the same time as breathing in through the         nose. Repeat in the other nostril.

    6. Wipe nozzle and keep it dry after use. Put the protective cap back on.
Safety information

Under normal conditions of use, as indicated, Otrivin Baby Care Moisturising Nasal Spray is very well tolerated. If you have any further questions on the use of this product, ask your doctor or pharmacist.
How to Store Otrivin Baby Care Moisturising Nasal Spray

Keep out of reach and sight of children.

Do not use the product after the expiry date shown on the packaging. Store between 0° and 30°.

Protect from heat. Store in the original packaging.

Promotion of Access to Information Act (PAIA)

The PAIA manual is prepared in accordance with section 51 of the Promotion of Access to Information Act (PAIA) No. 2 of 2000 (as amended) and the Protection of Personal Information Act, 2013. The purpose of PAIA is to promote the right of access to information, to foster a culture of transparency and accountability within the Company by giving the right to information that is required for the exercise or protection of any right and to actively promote a society in which the people of South Africa have effective access to information to enable them to exercise and protect their rights.

Please see the PAIA manual.

S1 Otrivin Adult Drops. Each 1 ml contains 1 mg of xylometazoline hydrochloride. Preservative: benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1382.
S1 Otrivin Adult Nasal Metered-dose Spray. Each 1 ml contains 1 mg of xylometazoline hydrochloride. Preservative: benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1382.

* class-specific comparison (topical vs systemic decongestant)

Ref 1. Eccles R. Over the counter medicines for colds. In: Common Cold. Eccles R & Weber O, eds. Basel, Switzerland: Birkhäuser Verlag; 2009. (see reference here)

Ref 2. Eccles R, Eriksson M, Garreffa S, et al. The nasal decongestant effect of xylometazoline in the common cold. Am J Rhinol. 2008;22(5):491–6 (see reference here)

S1 OTRIVIN Menthol Nasal Metered-dose Spray. Each 1 ml contains 1 mg of xylometazoline hydrochloride. Preservative: benzalkonium chloride 0.01% m/v. Reg. no.: 31/16.1/0319.
S1 OTRIVIN Paed. Drops. Each 1 ml contains 0,5 mg of xylometazoline hydrochloride. Preservative: benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1381.
S1 OTRIVIN Paed. Nasal Metered-dose Spray. Each 1 ml contains 0, 5 mg of xylometazoline hydrochloride. Preservative: Benzalkonium chloride 0.01 % m/v. Reg. no.: H/16.1/1381.
Otrivin Sea Water with Aloe Vera Nasal Spray / Otrivin Sea Water with Eucalyptus Nasal Spray /
Otrivin Baby Care - Moisturising Nasal Spray

Applicant: GlaxoSmithKline Consumer Healthcare South Africa (Pty) Limited, 39 Hawkins Avenue, Epping Industria 1, Cape Town, 7460.

Company reg. no.: 2014/173930/07. For full prescribing information refer to the professional information approved by the medicines regulatory authority. Always read label prior to use.

For any further information, including safety and adverse reactions, please contact the GSK Hotline on 0800 007 018 or mystory.za@haleon.com.

This website is intended for residents of South & Southern African residents only.

* We do not supply our products directly to consumers. By selecting the Buy Now*/Try Now button on this page, you will be re-directed to a list of retailers’ websites for purchase. Kindly note that purchase will be subject to stock availability.

PM-ZA-OTRI-21-00023
PM-ZA-OTRI-23-00017